We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
GERN

Price
1.51
Stock movement down
-0.04 (-2.58%)
Company name
Geron Corporation
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
963.41M
Ent value
1.01B
Price/Sales
32.68
Price/Book
3.30
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
16.08%
1 year return
-67.67%
3 year return
5.66%
5 year return
-2.11%
10 year return
-9.39%
Last updated: 2025-08-27

DIVIDENDS

GERN does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales32.68
Price to Book3.30
EV to Sales34.38

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count638.02M
EPS (TTM)-0.30
FCF per share (TTM)-0.33

Income statement

Loading...
Income statement data
Revenue (TTM)29.48M
Gross profit (TTM)28.46M
Operating income (TTM)-207.97M
Net income (TTM)-201.19M
EPS (TTM)-0.30
EPS (1y forward)-0.02

Margins

Loading...
Margins data
Gross margin (TTM)96.53%
Operating margin (TTM)-705.46%
Profit margin (TTM)-682.48%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash60.34M
Net receivables28.01M
Total current assets398.06M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment4.65M
Total assets402.71M
Accounts payable13.73M
Short/Current long term debt15.70M
Total current liabilities137.93M
Total liabilities110.42M
Shareholder's equity292.28M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-214.97M
Capital expenditures (TTM)885.00K
Free cash flow (TTM)-215.86M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-68.84%
Return on Assets-49.96%
Return on Invested Capital-65.64%
Cash Return on Invested Capital-70.43%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.57
Daily high1.58
Daily low1.49
Daily Volume10.8M
All-time high65.99
1y analyst estimate3.63
Beta0.73
EPS (TTM)-0.30
Dividend per share-
Ex-div date-
Next earnings date6 Nov 2025

Downside potential

Loading...
Downside potential data
GERNS&P500
Current price drop from All-time high-97.71%-3.04%
Highest price drop-98.66%-56.47%
Date of highest drop18 Mar 20209 Mar 2009
Avg drop from high-85.67%-11.04%
Avg time to new high234 days12 days
Max time to new high6361 days1805 days
COMPANY DETAILS
GERN (Geron Corporation) company logo
Marketcap
963.41M
Marketcap category
Small-cap
Description
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
Employees
229
Investor relations
-
SEC filings
CEO
John A. Scarlett
Country
USA
City
Menlo Park
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...